HLA-DR class II associations with rubella vaccine-induced joint manifestations

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 5-12

  Mitchell, Leslie Ann ^a   Tingle, Aubrey J ^b   MacWilliam, Laurie ^b   Home, Cathy ^b   Keown, Paul ^b   Gaur, Lakshmi K ^b   Nepom, Gerald T ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; RUBELLA VACCINE;

ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; FEMALE; HLA TYPING; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MEASLES VACCINATION; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; VIRUS INFECTION;

EID: 0031964964     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513807     Document Type: Article

References (18)

1. Howson CP, Howe CJ, Fineberg HV, eds. Adverse Effects of Pertussis and Rubella Vaccines. A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines, Division of Health Promotion and Disease Prevention, Institute of Medicine. Washington, DC: National Academy Press, 1991.
2. Tingle AJ, Allen M, Petty RE, Kettlyls GD, Chantler JK. Rubella-associated arthritis: I. comparative study of joint manifestations associated with natural rubella infection and RA27/3 rubella immunisation. Ann Rheum Dis 1986;45:110-4.
3. Howson CP, Katz M, Johnston RB, Fineberg HV. Chronic arthritis after rubella vaccination. Clin Infect Dis 1992;15:307-12.
4. Tingle AJ, Pot KH, Chantler JK. Prolonged arthritis, viraemia, hypogammaglobulinemia, and failed seroconversion following rubella immunization [letter]. Lancet 1984;1:1475-6.
5. Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis 1985;152:606-12.
6. Ray P, Black S, Shinefeld J, et al. Retrospective cohort evaluation of chronic rubella vaccine arthropathy [abstract]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994.
7. Slater PE, Ben-Zvi T, Fogel A, Ehrenfeld M, Ever-Hadani S. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine 1995;13:1529-32.
8. Tingle AJ, Mitchell LA, Grace M, et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 1997;349:1277-82.
9. Nepom GT, Ehrlich H. MHC class II molecules and autoimmunity. Ann Rev Immunol 1991;9:493-525.
10. Nepom B. The immunogenetics of juvenile rheumatoid arthritis. Pediatr Rheumatol 1991;17:825-42.
11. Mitchell LA, Tingle AJ, Shukin R, Sangeorzan JA, McCune J, Braun DK. Chronic rubella vaccine-associated arthropathy. Arch Intern Med 1993;153:2268-74.
12. Ogra PL, Chiba Y, Ogra SS. Rubella-virus infection in juvenile rheumatoid arthritis. Lancet 1975;1:1157-61.
13. Chantler JK, Tingle AJ, Petty RE. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 1985;313:1117-23.
14. Epstein G, Bums S, Prenty P. Antigen frequencies for HLA loci in British Columbian Caucasians [abstract]. In: Program and abstracts of Canadian Society of Laboratory Technology National Congress (Vancouver, Canada), 1994.
15. Leech NJ, Kitabchi AE, Gaur LK, et al. Genetic and immunological markers of insulin dependent diabetes in American blacks. Autoimmunity 1995;22:27-32.
16. Cooper SM, Roessner KD, Naito-Hoopes M, Howard DB, Gaur LK, Budd RC. Increased usage of Vβ2 and Vβ6 in rheumatoid synovial fluid T-cells. Arthritis Rheum 1994;37:1627-36.
17. Erlick HJ, Bugawan T, Begovitch AB. HLA-DR, -DQ, and -DP typing using PCR amplification and immobilized probes. Eur J Immunogen 1991;18:33-55.
18. Gaur LK, Nepom GT, Snyder KE, et al. MHC-DRB allelic sequences incorporate distinct intragenic trans-specific segments. Tissue Antigens 1997;49:342-55.